Literature DB >> 17597616

Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy.

Ruifang Li1, Wenhua Zheng, Rongbiao Pi, Jie Gao, Huijie Zhang, Ping Wang, Kang Le, Peiqing Liu.   

Abstract

Activation of peroxisome proliferator-activated receptor-alpha (PPAR-alpha) has been recently reported to inhibit vascular inflammatory response and prevent cardiac hypertrophy. However, it is unclear how the activation of PPAR-alpha regulates hypertrophic response. In the present study, we found that application of fenofibrate and overexpression of PPAR-alpha inhibited endothelin-1 (ET-1)-induced phosphorylation of protein kinase B (Akt) at Ser473 and glycogen synthase kinase3beta (GSK3beta) at Ser9, and prevented ET-1-induced nuclear translocation of NFATc4 in cardiomyocytes. Moreover, co-immunoprecipitation studies showed that fenofibrate strongly induced the association of nuclear factor of activated T cells (NFATc4) with PPAR-alpha. These results suggest that activation of PPAR-alpha inhibits ET-1-induced cardiac hypertrophy through regulating PI3K/Akt/GSK3beta and NFAT signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597616     DOI: 10.1016/j.febslet.2007.06.017

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.

Authors:  Qi Li; Xi Lin; Xiangsheng Yang; Jiang Chang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

2.  Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia.

Authors:  Mary K Swinton; Aliyah Carson; Francesca Telese; Ana B Sanchez; Benchawanna Soontornniyomkij; Leila Rad; Isabella Batki; Brandi Quintanilla; Josué Pérez-Santiago; Cristian L Achim; Scott Letendre; Ronald J Ellis; Igor Grant; Anne N Murphy; Jerel Adam Fields
Journal:  Neurobiol Dis       Date:  2019-06-22       Impact factor: 5.996

Review 3.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

4.  Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72.

Authors:  Harlokesh Narayan Yadav; Manjeet Singh; Pyare Lal Sharma
Journal:  Mol Cell Biochem       Date:  2012-07-19       Impact factor: 3.396

Review 5.  The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.

Authors:  Kristine M Wadosky; Monte S Willis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

6.  PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.

Authors:  Kang Le; Ruifang Li; Suowen Xu; Xiaoqian Wu; Heqing Huang; Yingxia Bao; Yi Cai; Tian Lan; Joel Moss; Cuixian Li; Jian Zou; Xiaoyan Shen; Peiqing Liu
Journal:  Arch Biochem Biophys       Date:  2011-12-16       Impact factor: 4.013

Review 7.  Minireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart.

Authors:  Pamela Lockyer; Jonathan C Schisler; Cam Patterson; Monte S Willis
Journal:  Mol Endocrinol       Date:  2009-12-16

8.  Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.

Authors:  Anita Y M Chan; Vernon W Dolinsky; Carrie-Lynn M Soltys; Benoit Viollet; Shairaz Baksh; Peter E Light; Jason R B Dyck
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

9.  Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.

Authors:  Magali Dumont; Cliona Stack; Ceyhan Elipenahli; Shari Jainuddin; Meri Gerges; Natalia Starkova; Noel Y Calingasan; Lichuan Yang; Davide Tampellini; Anatoly A Starkov; Robin B Chan; Gilbert Di Paolo; Aurora Pujol; M Flint Beal
Journal:  Hum Mol Genet       Date:  2012-08-24       Impact factor: 6.150

10.  Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.

Authors:  Yingxia Bao; Ruifang Li; Jianmin Jiang; Birong Cai; Jie Gao; Kang Le; Fangyan Zhang; Shaorui Chen; Peiqing Liu
Journal:  Mol Cell Biochem       Date:  2008-07-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.